Science blog

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster.

More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.

Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.

We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.

2020 has seen people across the globe impacted by the ongoing COVID-19 pandemic. Science is no exception – with many…

We caught up with 4 people with cancer during the pandemic in part 8 of our Coronvirus reports.